Scleroderma physical examination: Difference between revisions
Jump to navigation
Jump to search
| Line 63: | Line 63: | ||
===Extremities=== | ===Extremities=== | ||
*Myopathy<ref name="pmid23541012">{{cite journal |vauthors=Shah AA, Wigley FM |title=My approach to the treatment of scleroderma |journal=Mayo Clin. Proc. |volume=88 |issue=4 |pages=377–93 |date=April 2013 |pmid=23541012 |pmc=3666163 |doi=10.1016/j.mayocp.2013.01.018 |url=}}</ref> | *Myopathy<ref name="pmid23541012">{{cite journal |vauthors=Shah AA, Wigley FM |title=My approach to the treatment of scleroderma |journal=Mayo Clin. Proc. |volume=88 |issue=4 |pages=377–93 |date=April 2013 |pmid=23541012 |pmc=3666163 |doi=10.1016/j.mayocp.2013.01.018 |url=}}</ref> | ||
*Ulceration of finger tips (ischemic) | *Ulceration of finger tips (ischemic)<ref name="pmid19487217">{{cite journal |vauthors=Krieg T, Takehara K |title=Skin disease: a cardinal feature of systemic sclerosis |journal=Rheumatology (Oxford) |volume=48 Suppl 3 |issue= |pages=iii14–8 |date=June 2009 |pmid=19487217 |doi=10.1093/rheumatology/kep108 |url=}}</ref> | ||
*Contractures of finger flexion | *Contractures of finger flexion | ||
*Raynaud's phenomenon<ref name="pmid12324557">{{cite journal |vauthors=Wigley FM |title=Clinical practice. Raynaud's Phenomenon |journal=N. Engl. J. Med. |volume=347 |issue=13 |pages=1001–8 |date=September 2002 |pmid=12324557 |doi=10.1056/NEJMcp013013 |url=}}</ref> | *Raynaud's phenomenon<ref name="pmid12324557">{{cite journal |vauthors=Wigley FM |title=Clinical practice. Raynaud's Phenomenon |journal=N. Engl. J. Med. |volume=347 |issue=13 |pages=1001–8 |date=September 2002 |pmid=12324557 |doi=10.1056/NEJMcp013013 |url=}}</ref> | ||
Revision as of 23:52, 17 April 2018
|
Scleroderma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scleroderma physical examination On the Web |
|
American Roentgen Ray Society Images of Scleroderma physical examination |
|
Risk calculators and risk factors for Scleroderma physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].
OR
Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
The presence of [finding(s)] on physical examination is diagnostic of [disease name].
OR
The presence of [finding(s)] on physical examination is highly suggestive of [disease name].
Physical Examination
- Physical examination of patients with scleroderma is usually remarkable for:[finding 1], [finding 2], and [finding 3].
- The presence of [finding(s)] on physical examination is diagnostic of [disease name].
- The presence of [finding(s)] on physical examination is highly suggestive of [disease name].
Appearance of the Patient
- Patients with [disease name] usually appear [general appearance].
Vital Signs
- Vital signs of patients with scleroderma are usually normal
Skin
HEENT
- HEENT examination of patients with scleroderma is usually normal.
Neck
- Jugular venous distention maybe present suggesting right heart failure due to pulmonary hypertension.
Lungs
- Pulmonary examination of patients with scleroderma is usually normal.
- Inspiratory crackles upon auscultation of the lung are suggestive of interstitial lung disease.
Heart
- Right ventricular heave can be suggestive of pulmonary arterial hypertension (PAH)
Abdomen
Back
- Back examination of patients with scleroderma is usually normal.
Genitourinary
- Genitourinary examination of patients with scleroderma is usually normal.
Neuromuscular
- Neuromuscular examination of patients with scleroderma is usually normal.
Extremities
- Myopathy[1]
- Ulceration of finger tips (ischemic)[2]
- Contractures of finger flexion
- Raynaud's phenomenon[3]
- Dilatation of nailfold capillaries
- Sclerodactyly
References
- ↑ 1.0 1.1 Shah AA, Wigley FM (April 2013). "My approach to the treatment of scleroderma". Mayo Clin. Proc. 88 (4): 377–93. doi:10.1016/j.mayocp.2013.01.018. PMC 3666163. PMID 23541012.
- ↑ 2.0 2.1 Krieg T, Takehara K (June 2009). "Skin disease: a cardinal feature of systemic sclerosis". Rheumatology (Oxford). 48 Suppl 3: iii14–8. doi:10.1093/rheumatology/kep108. PMID 19487217.
- ↑ Wigley FM (September 2002). "Clinical practice. Raynaud's Phenomenon". N. Engl. J. Med. 347 (13): 1001–8. doi:10.1056/NEJMcp013013. PMID 12324557.